Reading Time: 7 minutes Global biotechnology company Biogen has announced plans to make tofersen, a potential treatment for people whose MND is believed to be driven by mutations in
Month: July 2021
Reading Time: 4 minutes We recently announced that following the success of our first virtual International Symposium on ALS/MND (the largest medical and scientific conference specific to MND/ALS) last